Mechanisms of hepatic toxicity. IV. Pathogenetic mechanisms involved in hepatitis C virus-induced liver diseases

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 275, Issue 6 38-6, 1998, Pages

  Lau, Johnson Yiu Nam ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEPATITIS; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CYTOPATHOGENIC EFFECT; FIBROGENESIS; HEPATITIS C; HUMAN; IMMUNOPATHOLOGY; LIVER CIRRHOSIS; LIVER INJURY; LIVER REGENERATION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0032418843     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1998.275.6.g1217     Document Type: Article

References (30)

1. Barba, G., F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M. J. Chapman, T. Miyamura, and C. Brechet. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA 94: 1200-1205, 1997.
2. Bertoletti, A., M. M. D'Elios, C. Boni, M. De Carli, A. L. Zignego, M. Durazzo, G. Missale, A. Penna, F. Fiaccadori, G. Del Prete, and C. Ferrari. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and C virus infection. Gastroenterology 112: 193-199, 1997.
3. Bhardwaj, G., T. Ohno, M. Mizokami, R. G. Gish, and J. Y. N. Lau. Host immune response in liver in chronic hepatitis C: both perform and fas-ligand pathways are activated (Abstract). Gastroenterology 110: A1152, 1996.
4. Botarelli, P., M. R. Brunetto, M. A. Minutello, P. Calvo, D. Unutmaz, A. J. Weiner, Q. L. Choo, J. R. Shuster, G. Kuo, F. Bonino, M. Houghton, and S. Abrignani. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 194: 580-587, 1993.
5. Cooper, S., A. Erickson, D. Chien, A. Weiner, M. Houghton, P. Parham, and C. Walker. CD8+ CTL directed against multiple hepatitis C viral proteins early in the course of infection correlate with immunity and endure following viral clearance (Abstract). Joint U.S.-Japan Hepatitis Panel Conference 19th Monterey, CA, 1998. p. 5.
6. Diepolder, H. M., R. Zachoval, R. M. Hoffman, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007, 1995.
7. Fang, J. W. S., R. P. Gonzalez-Peralta, J. A. Gottschall, G. L. Davis, R. G. Gish, M. Mizokami, and J. Y. N. Lau. Hepatic expression of c-Fas and apoptosis in chronic hepatitis C virus infection (Abstract). Hepatology 20: 250A, 1994.
8. Fang, J. W. S., G. K. K. Lau, C. G. Marousis, R. P. Gonzalez-Peralta, G. L. Davis, R. Gish, R. W. Moyer, K. J. Kao, R. Lesniewski, M. Mizokami, M. Houghton, and J. Y. N. Lau. Failure to detect cell surface expression of hepatitis C structural proteins using a vaccinia expression system (Abstract). Gastroenterology 106: A890, 1994.
9. Farci, P., H. J. Alter, S. Govindarajan, D. C. Wong, R. Engle, R. R, Lesniewski, I. K. Mushahwar, S. M. Desai, R. H. Miller, N. Ogata, and R. H. Purcell. Lack of protective immunity against reinfection with hepatitis C virus. Science 258: 135-140, 1992.
10. Farci, P., H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R. H. Purcell. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91: 7792-7796, 1994.
11. Friedman, S. L. Molecular mechanisms of hepatic fibrosis and principle of therapy. J. Gastroenterol. 32: 424-430, 1997.
12. Garcia-Monzon, C., F. Sanchez-Madrid, L. Garcia-Buey, A. Garcia-Arroyo, A. Garcia-Sanchez, and R. Moreno-Otero. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 108: 231-241, 1995.
13. Hoffmann, R. M., H. M. Diepolder, R. Zachoval, F. M. Zwiebel, M. C. Jung, S. Scholz, H. Nitschko, G. Riethmuller, and G. R. Pape. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21: 632-638, 1995.
14. Jarvis, J. N., J. Kaplan, and N. Fine. Increase in CD5+ B-cells in juvenile rheumatoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity. Arthritis Rheum. 35: 204-207, 1992.
15. Kawamura, T., A. Furusaka, M. J. Koziel, R. T. Chung, T. C. Wang, E. V. Schmidt, and T. J. Liang. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 25: 1014-1021, 1997.
16. Kobayashi, K., E. Hashimoto, J. Ludwig, T. Hisamitsu, and H. Obata. Liver biopsy features of acute hepatitis C compared with hepatitis A, B, and non-A, non-B, non-C. Liver 13: 69-73, 1993.
17. Koziel, M. J., D. Dudley, N. Afdhal, A. Grakoui, C. M. Rice, Q. L. Choo, M. Houghton, and B. D. Walker. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C. Identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96: 2311-2321, 1995.
18. Lau, J. Y. N., S. E. Davies, V. G. Bain, J. G. O'Grady, A. Alberti, G. J. M. Alexander, and R. Williams. High level expression of hepatitis B viral antigen in fibrosing cholestatic hepatitis; evidence that HBV may be cytopathic in liver grafts. Gastroenterology 102: 956-962, 1992.
19. Lau, J. Y. N., K. Krawczynski, F. Negro, and R. P. Gonzalez-Peralta. In situ detection of hepatitis C virus - a critical appraisal. J. Hepatol. 4, Suppl. 2: 43-51, 1996.
20. Lim, H. L., G. K. K. Lau, G. L. Davis, D. Dolson, and J. Y. N. Lau. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 106: 248-251, 1994.
21. Minutello, M. A., P. Pleri, D. Unutmaz, S. Censini, G. Kuo, M. Houghton, M. R. Brunetto, F. Bonino, and S. Abrignani. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cell specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. 178: 17-25, 1993.
22. Napoli, J., G. A. Bishop, P. H. McGuinness, D. M. Painter, and G. W. McCaughan. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24: 759-765, 1996.
23. Nelson, D. R., and J. Y. N. Lau. Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection. Clin. Liver Dis. 1: 515-528, 1997.
24. Nelson, D. R., C. G. Marousis, G. L. Davis, C. M. Rice, J. Wong, M. Houghton, and J. Y. N. Lau. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158: 1473-1481, 1997.
25. Nelson, D. R., C. G. Marousis, T. Ohno, G. L. Davis, and J. Y. N. Lau. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon a therapy in chronic hepatitis C. Hepatology 28: 225-230, 1998.
26. Onji, M., T. Kikuchi, I. Kumon, T. Masumoto, S. Ndano, K. Kajino, N. Horikee, and Y. Ohta. Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C. Hepatogastroenterology 39: 340-343, 1992.
27. Pozzato, G., and M. Moretti. Lymphocyte subsets in HCV-positive chronic liver disease. Immunol. Today 15: 137-138, 1994.
28. Reiser, M., C. G. Marousis, D. R. Nelson, G. Lauer, R. P. Gonzalez-Peralta, G. L. Davis, and J. Y. N. Lau. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J. Hepatol. 26: 471-478, 1997.
29. Schluger, L. K., P. A. Sheiner, S. N. Thung, J. Y. N. Lau, A. Min, D. C. Wolf, I. Fiel, D. Zhang, M. A. Gerber, C. M. Miller, and H. C. Bodenheimer. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 25: 971-976, 1996.
30. Wu, P. C., J. W. S. Fang, C. Dong, Q. L. Choo, M. Houghton, and J. Y. N. Lau. Ultrastructural changes in cells expressing HCV structural proteins: implications on pathogenesis (Abstract). Hepatology 24: 263A, 1996.